Skip to content

Globus Medical Inc (GMED) stock: revenue, earnings & dividend

Globus Medical Inc (GMED, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener GMED · NYSE Medizintechnik & Messgeräte US-PA

Key figures

Fiscal year
2025
Revenue
2.94 bn $
Revenue growth
16.7 %
Revenue growth 5y (p.a.)
30.1 %
Net income
538 m $
Net margin
18.3 %
Operating margin
16.3 %
Earnings per share (diluted)
3.92 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
5.3 bn $
Equity
4.57 bn $
Equity ratio
86.2 %
Return on equity
11.8 %
Cash
526 m $
Operating cash flow
753 m $
Free cash flow
589 m $
Shares outstanding
134,261,914

History

Revenue by fiscal year

2016 564 m $
2017 636 m $
2018 713 m $
2019 785 m $
2020 789 m $
2021 958 m $
2022 1.02 bn $
2023 1.57 bn $
2024 2.52 bn $
2025 2.94 bn $

Net income by fiscal year

2016 104 m $
2017 107 m $
2018 156 m $
2019 155 m $
2020 102 m $
2021 149 m $
2022 190 m $
2023 123 m $
2024 103 m $
2025 538 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20252.94 bn $538 m $3.92 $–753 m $
20242.52 bn $103 m $0.75 $–521 m $
20231.57 bn $123 m $1.07 $–243 m $
20221.02 bn $190 m $1.85 $–178 m $
2021958 m $149 m $1.44 $–276 m $
2020789 m $102 m $1.01 $–199 m $
2019785 m $155 m $1.52 $–172 m $
2018713 m $156 m $1.54 $–182 m $
2017636 m $107 m $1.10 $–159 m $
2016564 m $104 m $1.08 $–148 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)